Ambiguities dot India's proposed SAE compensation norms
This article was originally published in Scrip
Executive Summary
India's proposed norms to determine the amount of compensation given in the case of clinical trial-related injury other than death appear to have a number of ambiguities including in areas concerning determining the exact extent of disability that entitles a participant for compensation.